Project Assistant in Clinical Genetics

Description of the workplace
At the Division of Clinical Genetics, Department of Laboratory Medicine, we are seeking a project assistant who will work within a research project aimed at developing new antibody-based treatment strategies for blood cancers.

The project focuses on using antibodies to selectively target blood cancer cells. A particular focus is on linking antibodies to so-called protein degraders, such as PROTAC-like molecules, to enable targeted degradation of proteins that are essential for the growth and survival of blood cancer cells.

The research group is led by Professor Thoas Fioretos and consists of approximately ten members with expertise in advanced flow cytometry, single-cell analysis, bioinformatics, antibody technology, as well as experimental in vitro and in vivo models. The group is international, works in a multidisciplinary manner, and has established collaborations with other research groups, healthcare, and the life science industry.

We are now looking for a motivated project assistant with an interest in translational cancer research and antibody-based therapy development. The successful candidate is expected to be able to work both independently and in close collaboration with other members of the project.

As a workplace, we value a positive working environment characterised by respect, consideration, and an open, collaborative atmosphere.

We offer
Lund University is a public authority, which means that you benefit from special advantages, generous annual leave, and an attractive occupational pension. Read more about working with us on the university’s website: Work at Lund University

Duties and responsibilities
You will work as part of a team investigating the effects of different PROTAC-like molecules on blood cancer cells and whether their effects can be enhanced when linked to antibodies that are internalized in the cells. The duties include work with antibodies, protein degraders, internalization assays, cell culture, FACS analyses, and various functional assays.

Qualifications
Requirements for the position are:

• A Master’s degree in biomedicine or equivalent with a specialization in antibodies and blood cancer
• Extensive knowledge and documented experience working with various in vitro and in vivo models of blood cancer
• Extensive knowledge and documented experience of laboratory work involving FACS, blood cancer cells, immunological cells, and therapeutic antibodies
• Extensive knowledge and documented experience in evaluating the effects of PROTAC-like molecules linked to antibodies
• Strong and documented ability to work both independently and collaboratively with multiple partners
• Excellent proficiency in Swedish and English

Additional qualifications considered an asset:

• Experience of team-based work in a larger research group focused on the development of antibody-based therapies for blood cancer
• Good ability to write scientific texts and to continuously summarize and present scientific results

Other
The position is a fixed-term employment (SÄVA) at full-time (100%), limited to one year, starting on 1 July 2026, or as soon as possible by agreement.

How to apply
The position is applied for via the university’s recruitment system. The application must include a personal letter explaining why you are interested in the position and how your qualifications match the requirements. The application must also include a CV, degree certificate, and other relevant certificates demonstrating that you meet the requirements above.